Literature DB >> 15670157

Identification of functional domains in the formyl peptide receptor-like 1 for agonist-induced cell chemotaxis.

Yingying Le1, Richard D Ye, Wanghua Gong, Jianxiang Li, Pablo Iribarren, Ji Ming Wang.   

Abstract

Formyl peptide receptor-like 1 (FPRL1) is a seven transmembrane domain, G protein-coupled receptor that interacts with a variety of exogenous and host-derived agonists. In order to identify domains crucial for ligand recognition by FPRL1, we used chimeric receptors with segments in FPRL1 replaced by corresponding amino acid sequences derived from the prototype formyl peptide receptor FPR. The chimeric receptors were stably transfected into human embryonic kidney epithelial cells and the capacity of the cells to migrate in response to formyl peptide receptor agonists was evaluated. Our results showed that multiple domains in FPRL1 are involved in the receptor response to chemotactic agonists with the sixth transmembrane domain and the third extracellular loop playing a prominent role. Interestingly, the N-terminus and a segment between the fourth transmembrane domain and the third intracellular loop of FPRL1 are important for receptor interaction with a 42 amino acid amyloid beta peptide (Abeta42), an Alzheimer's disease-associated FPRL1 agonist, but not with MMK-1, a synthetic FPRL1 agonist, suggesting that diverse agonists may use different domains in FPRL1. Considering the potential importance of FPRL1 in inflammation and neurodegenerative diseases, the identification of functional domains in this receptor will provide valuable information for the design of specific receptor antagonists.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15670157     DOI: 10.1111/j.1742-4658.2004.04514.x

Source DB:  PubMed          Journal:  FEBS J        ISSN: 1742-464X            Impact factor:   5.542


  16 in total

1.  Human neutrophil formyl peptide receptor phosphorylation and the mucosal inflammatory response.

Authors:  Giovanna Leoni; Jeannie Gripentrog; Connie Lord; Marcia Riesselman; Ronen Sumagin; Charles A Parkos; Asma Nusrat; Algirdas J Jesaitis
Journal:  J Leukoc Biol       Date:  2014-11-13       Impact factor: 4.962

2.  The green tea polyphenol (-)-epigallocatechin-3-gallate inhibits leukocyte activation by bacterial formylpeptide through the receptor FPR.

Authors:  Jingjing Zhu; Oumei Wang; Lingfei Ruan; Xinwei Hou; Youhong Cui; Ji Ming Wang; Yingying Le
Journal:  Int Immunopharmacol       Date:  2009-05-06       Impact factor: 4.932

Review 3.  International Union of Basic and Clinical Pharmacology. LXXIII. Nomenclature for the formyl peptide receptor (FPR) family.

Authors:  Richard D Ye; François Boulay; Ji Ming Wang; Claes Dahlgren; Craig Gerard; Marc Parmentier; Charles N Serhan; Philip M Murphy
Journal:  Pharmacol Rev       Date:  2009-06-04       Impact factor: 25.468

Review 4.  Annexin A1 and glucocorticoids as effectors of the resolution of inflammation.

Authors:  Mauro Perretti; Fulvio D'Acquisto
Journal:  Nat Rev Immunol       Date:  2009-01       Impact factor: 53.106

5.  Pro-Resolving Mediator Annexin A1 Regulates Intracellular Ca2+ and Mucin Secretion in Cultured Goblet Cells Suggesting a New Use in Inflammatory Conjunctival Diseases.

Authors:  Anne V Lyngstadaas; Markus V Olsen; Jeffrey A Bair; Robin R Hodges; Tor P Utheim; Charles N Serhan; Darlene A Dartt
Journal:  Front Immunol       Date:  2021-04-22       Impact factor: 7.561

6.  Mucosal gene expression profile of stricturing Crohn's disease: A preliminary study.

Authors:  Cristian George Tieranu; Andrei Ovidiu Olteanu; Carmen Monica Preda; Nicolae Bacalbasa; Elena Milanesi; Maria Dobre; Ioana Tieranu; Teodora Ecaterina Manuc; Artsiom Klimko; Gabriel Becheanu; Elena Mirela Ionescu
Journal:  Exp Ther Med       Date:  2021-12-16       Impact factor: 2.447

Review 7.  Distinct signaling cascades elicited by different formyl peptide receptor 2 (FPR2) agonists.

Authors:  Fabio Cattaneo; Melania Parisi; Rosario Ammendola
Journal:  Int J Mol Sci       Date:  2013-04-02       Impact factor: 5.923

8.  Annexin A1 N-terminal derived Peptide ac2-26 exerts chemokinetic effects on human neutrophils.

Authors:  Jesmond Dalli; Trinidad Montero-Melendez; Simon McArthur; Mauro Perretti
Journal:  Front Pharmacol       Date:  2012-02-28       Impact factor: 5.810

9.  Annexin A1 interaction with the FPR2/ALX receptor: identification of distinct domains and downstream associated signaling.

Authors:  Stefania Bena; Vincenzo Brancaleone; Ji Ming Wang; Mauro Perretti; Roderick J Flower
Journal:  J Biol Chem       Date:  2012-05-18       Impact factor: 5.157

10.  Anti-inflammatory role of the murine formyl-peptide receptor 2: ligand-specific effects on leukocyte responses and experimental inflammation.

Authors:  Mauro Perretti; Roderick J Flower; Neil Dufton; Robert Hannon; Vincenzo Brancaleone; Jesmond Dalli; Hetal B Patel; Mohini Gray; Fulvio D'Acquisto; Julia C Buckingham
Journal:  J Immunol       Date:  2010-01-27       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.